Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,303	11,851	23,035	22,785	63,653	21,743
Market Cap Growth	-7.17%	-48.55%	1.10%	-64.20%	192.75%	388.97%
Enterprise Value	13,775	10,382	21,271	20,540	62,660	22,145
Last Close Price	46.55	36.05	70.10	69.50	200.91	69.21
PE Ratio	-	-	-	-	45.14	-
PS Ratio	23.10	19.57	59.12	62.42	19.40	1889.56
PB Ratio	4.06	3.08	5.99	4.53	13.61	6.92
P/TBV Ratio	4.09	3.10	6.05	4.57	13.77	7.06
P/FCF Ratio	-	1835.64	-	-	142.64	-
P/OCF Ratio	-	290.80	-	-	109.77	-
EV/Sales Ratio	20.79	17.14	54.59	56.27	19.10	1924.50
EV/EBITDA Ratio	212.69	-	-	-	58.45	-
EV/EBIT Ratio	-	-	-	-	65.02	-
EV/FCF Ratio	-189.15	1608.05	-	-	140.41	-
Debt / Equity Ratio	0.09	0.09	0.51	0.39	0.04	0.06
Debt / EBITDA Ratio	5.17	-	-	-	0.17	-
Debt / FCF Ratio	-	52.50	-	-	0.42	-
Asset Turnover	0.13	0.12	0.06	0.06	0.75	0.00
Inventory Turnover	0.53	0.50	0.25	0.76	2.84	0.09
Quick Ratio	9.93	9.54	1.99	12.48	6.54	11.58
Current Ratio	12.61	11.94	2.21	15.38	8.48	12.48
Return on Equity (ROE)	-0.74%	-2.09%	-26.14%	-30.39%	36.08%	-29.91%
Return on Assets (ROA)	-0.88%	-1.74%	-11.29%	-15.18%	13.71%	-16.55%
Return on Capital (ROIC)	-0.91%	-1.82%	-11.85%	-16.21%	14.71%	-17.38%
Return on Capital Employed (ROCE)	-	-	-	-	19.80%	-
Earnings Yield	-0.18%	-0.68%	-5.04%	-6.47%	2.22%	-3.10%
FCF Yield	-0.48%	0.05%	-2.26%	-5.94%	0.70%	-3.17%
Buyback Yield / Dilution	-0.06%	-0.10%	-1.50%	-0.73%	-15.82%	-20.08%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.